¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"renal column of Bertin"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • renal cyst
    1. ÄáÆÏ³¶, ½ÅÀå³¶ 2. ÄáÆÏ³¶Á¾, ½ÅÀå³¶Á¾
  • renal disease
    ÄáÆÏº´, ½ÅÀ庴
  • renal disorder
    ÄáÆÏÀå¾Ö, ½ÅÀåÀå¾Ö
  • renal failure
    ÄáÆÏ±â´É»ó½Ç, ½ÅºÎÀü
  • renal function test
    ÄáÆÏ±â´É°Ë»ç, ½ÅÀå±â´É°Ë»ç
  • renal glycosuria
    ÄáÆÏ´ç´¢, ½ÅÀ强´ç´¢
  • renal hematuria
    ÄáÆÏÇ÷´¢, ½ÅÀ强Ç÷´¢
  • renal hypertension
    ÄáÆÏ°íÇ÷¾Ð, ½ÅÀ强°íÇ÷¾Ð
  • renal impression
    ÄáÆÏÀÚ±¹, ½ÅÀå¾ÐÈç
  • renal infundibulum
    ÄáÆÏ´ë·Õ, ½ÅÀå´©µÎ
  • renal nanism
    ÄáÆÏ³­ÀïÀÌ(Áõ), ½ÅÀ强³­ÀïÀÌ(Áõ)
  • renal osteodystrophy
    ½ÅÀ强°ñÇü¼ºÀå¾Ö, ÄáÆÏ»ÀÇü¼ºÀå¾Ö
  • renal papilla
    ÄáÆÏÀ¯µÎ, ½ÅÀåÀ¯µÎ
  • renal papillary necrosis
    ÄáÆÏÀ¯µÎ±«»ç, ½ÅÀåÀ¯µÎ±«»ç
  • renal pelvis
    ½Å¿ì, ÄáÆÏ±ò¶§±â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • radioisotope renal clearance method
    ¹æ»ç¼ºµ¿À§¿ø¼ÒÄáÆÏÁ¦°ÅÀ²ÃøÁ¤¹ý
  • necrotizing renal papillitis
    ±«»çÄáÆÏÀ¯µÎ¿°
  • renal nanism
    ÄáÆÏ³­ÀåÀÌÁõ
  • renal cortical necrosis
    ÄáÆÏ°ÑÁú±«»ç
  • renal papillary necrosis
    ÄáÆÏÀ¯µÎ±«»ç
  • renal tissue nephroblastoma
    ÄáÆÏÁ¶Á÷ÄáÆÏ¸ð¼¼Æ÷Á¾, ½ÅÀåÁ¶Á÷½ÅÀå¸ð¼¼Æ÷Á¾
  • renal osteodystrophy
    ÄáÆÏ»ÀÇü¼ºÀå¾Ö, ½ÅÀå°ñÇü¼ºÀå¾Ö
  • renal papilla
    ÄáÆÏÀ¯µÎ, ½ÅÀåÀ¯µÎ
  • renal pelvis
    ÄáÆÏ±ò¶§±â, ½Å¿ì
  • renal pyramid
    ÄáÆÏÇǶó¹Ô
  • renal
    ÄáÆÏ-, ½ÅÀå-
  • radionuclide renal scan
    ¹æ»ç¼±ÇÙÁ¾ÄáÆÏ½ºÄµ, ¹æ»ç¼±ÇÙÁ¾½ÅÀ彺ĵ
  • renal retinopathy
    ÄáÆÏ¸Á¸·º´Áõ, ½ÅÀå¸Á¸·º´Áõ
  • renal rickets
    ÄáÆÏ±¸·íº´, ½ÅÀ屸·íº´
  • renal segment
    ÄáÆÏ±¸¿ª
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • renal albuminuria
    ½Å¼º´Ü¹é´¢(ãìàõÓ±ÛÜèñ)
  • renal amino aciduria
    ½Å¼º ¾Æ¹Ì³ë»ê´¢
  • renal aminoaciduria
    ½Å¼º¾Æ¹Ì³ë»ê´¢(ãìàõ¡­ß«èñ).
  • renal aminoaciduria
    ½Å¼º¾Æ¹Ì³ë»ê´¢(¡­ß«èñ)
  • renal anasarca
    ½Å¼ºÀü½Å¼öÁ¾(ãìàõîïãóâ©ðþ).
  • renal anasarca
    ½Å¼ºÀü½Å¼öÁ¾(¡­îïãóâ©ðþ)
  • renal angiography
    ½ÅÇ÷°üÁ¶¿µ¼ú
  • renal angle
    ½Å°¢.
  • renal anuria
    ½Å¼º¹«´¢(ãìàõÙíèñ).
  • renal anuria
    ½Å¼º¹«´¢(¡­Ùíèñ)
  • renal aplasia
    ½Å¹«Çü¼º(Áõ)(ãìÙíû¡à÷ñø)
  • renal apoplexy
    Æó´¢(øÍèñ)<Æó½Å>.
  • renal apoplexy
    Æó´¢(øÍèñ)<Æó½Å><øÍãì>
  • renal arterial occlusion
    ½Åµ¿¸Æ Æó»ö(ãìÔÑØæøÍßá).
  • renal arterial occlusion
    ½Åµ¿¸Æ Æó»ö(ãìÔÑØæøÍßá)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • posterior column ³ª comumna p.
    µîÂʱ⠵Õ, ÈÄÁÖ(ý­ñº).
  • posterior column ³ª comumna p.
    µîÂʱ⠵Õ, ÈÄÁÖ(ý­ñº).
  • rectal column
    Á÷Àå±âµÕ, Á÷ÀåÁÖ(òÁíóñº).
  • rectal column
    Á÷Àå±âµÕ, Á÷ÀåÁÖ(òÁ ñº).
  • spinal column
    ôÁÖ(ô±ñº).
  • striated column
    ÁÙ¹«´Ì±âµÕ
  • toracic column [nucleus dorsalis]
    °¡½¿±âµÕ [°¡½¿ÇÙ]
  • veins of vertebral column
    ôÁÖÁ¤¸Æ
  • vertebral column
    ôÁÖ(ô±ñº).
  • vertebral column
    ôÁÖ
  • vertical column
    ¼öÁ÷±âµÕ.
  • accessory renal calyx
    ºÎ(Á¸)½Å¹è
  • acute renal failure
    ±Þ¼º ½ÅºÎÀü(Áõ)(¡­ãìÝÕîïñø).
  • aluminium,renal osteodystrophy
    ½Å¼º °ñÀÌ¿µ¾çÁõ(ãìàõ Íéì£ç½å×ñø)
  • aortic renal ganglia
    ´ëµ¿¸ÆÄáÆÏ½Å°æÀý
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • Renal calyx
    ÄáÆÏ¼úÀÜ
    [¿¾ ¿ë¾î] ½Å¹è
  • Renal plexus
    ÄáÆÏ½Å°æ¾ó±â
    [¿¾ ¿ë¾î] ½Å½Å°æÃÑ
  • Renal ganglia
    ÄáÆÏ½Å°æÀý
    [¿¾ ¿ë¾î] ½Å½Å°æÀý
  • Renal lobe
    ÄáÆÏ¿±
    [¿¾ ¿ë¾î] ½ÅÀå¼Ò¿±
  • Renal lobes
    ÄáÆÏ¿±
    [¿¾ ¿ë¾î] ½Å¿±
  • Renal papilla
    ÄáÆÏÀ¯µÎ
    [¿¾ ¿ë¾î] ½ÅÀ¯µÎ
  • Renal papillae
    ÄáÆÏÀ¯µÎ
    [¿¾ ¿ë¾î] ½ÅÀ¯µÎ
  • Renal impression
    ÄáÆÏÀÚ±¹
    [¿¾ ¿ë¾î] ½Å¾ÐÈç
  • Renal veins
    ÄáÆÏÁ¤¸Æ
    [¿¾ ¿ë¾î] ½ÅÁ¤¸Æ
  • Renal tissue (Nephroblastoma)
    ÄáÆÏÁ¶Á÷ (ÄáÆÏ¸ð¼¼Æ÷Á¾)
    [¿¾ ¿ë¾î] ½ÅÁ¶Á÷
  • Renal pyramid
    ÄáÆÏÇǶó¹Ô
    [¿¾ ¿ë¾î] ½ÅÃßü
  • Renal pyramids
    ÄáÆÏÇǶó¹Ô
    [¿¾ ¿ë¾î] ½ÅÃßü
  • Renal capsule
    ÄáÆÏÇǸ·
    [¿¾ ¿ë¾î] ½ÅÇǸ·
  • Renal blood vessel
    ÄáÆÏÇ÷°ü
    [¿¾ ¿ë¾î] ½ÅÀåÇ÷°ü
  • Major renal calices
    Å«(ÄáÆÏ)¼úÀÜ
    [¿¾ ¿ë¾î] ´ë½Å¹è
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
CRT cadaveric renal transplant; cardiac resuscitation team; cathode-ray tube; certified; Certified Recor...
RVRA renal vein rein activity; renal venous renin assay
SRF severe renal failure; skin reactive factor; somatotropin-releasing factor; split renal function; sub...
ARF Acute Renal Failure
CRF   1) Chronic Renal Failure
  2) Corticotropin-Releasing Factor
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
CRF CHRONIC RENAL FAILURE
CRD Chronic renal disease
CRI Chronic renal insufficiency
CRG Compensatory renal growth
CRRT Continuous Renal Replacement Therapy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • renal colicky pain
    ½Å »êÅë
  • renal contusion
    ½Å Á»ó
  • renal cortical adenoma
    ½Å ÇÇÁú ¼±Á¾
  • renal counterbalance
    ½Å ÆòÇü, ½Å ÆòÇü·®
  • renal crisis
    ½Å ¹ßÁõ
  • renal cyst puncture
    ½Å ³¶Á¾ õÀÚ
  • renal damage
    ½Å Àå¾Ö
  • renal depressor system
    ½Å °­¾Ð°è
  • renal disease
    ½Å Áúȯ
  • renal dissociation jaundice
    ½Å ÇØ¸®¼º Ȳ´Þ
  • renal duct
    ½Å°ü
  • renal dysfunction
    ½Å ±â´É Àå¾Ö
  • renal dysplasia
    ½Å ÀÌÇü¼º, ½Å ÀÌÇü¼ºÁõ
  • renal ectopia
    ½Å ÀüÀ§, À̼Ҽº ½Å
  • renal failure
    ½Å ºÎÀü
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
acute renal failure <nephrology> A sudden decline in renal function may be triggered by a number of acute disease processes.
Examples include sepsis (infection), shock, trauma, kidney stones, kidney infection, drug toxicity (aspirin or lithium), poisons or toxins (drug abuse) or after injection with an iodinated contrast dye (adverse effect).
Chronic renal failure represents a slow decline in kidney function over time. Chronic renal failure may be caused by a number of disorders which include long-standing hypertension, diabetes, congestive heart failure, lupus or sickle cell anaemia. Both forms of renal failure result in a life-threatening metabolic derangement.
(27 Sep 1997)
aminoaciduria, renal Impairment of renal tubular transport of amino acids.
(12 Dec 1998)
back-pressure renal atrophy <radiology> Caliectasis without obstruction, due to repeated episodes of obstruction, gradual loss of renal pyramids
(12 Dec 1998)
base of renal pyramid The outer broad part of a renal pyramid that lies next to the cortex.
Synonym: basis pyramidis renis.
(05 Mar 2000)
branchio-oto-renal syndrome <syndrome> An autosomal dominant disorder manifested by various combinations of preauricular pits, branchial fistulae or cysts, lacrimal duct stenosis, hearing loss, structural defects of the outer, middle, or inner ear, and renal dysplasia. Associated defects include asthenic habitus, long narrow facies, constricted palate, deep overbite, and myopia. Hearing loss may be due to mondini type cochlear defect and stapes fixation.
(12 Dec 1998)
capsular branches of renal artery <anatomy, artery> Branches arising from the renal artery outside of the kidney that are distributed to the renal capsule.
Synonym: rami capsulares arteriae renalis.
(05 Mar 2000)
captopril renal scan <radiology> In a kidney with a lesion in the afferent arteriole (e.g. Atherosclerotic plaque), reflex constriction of the efferent arteriole occurs through angiotensin system thus maintaining renal perfusion. ACE inhibition prevents constriction of efferent arteriole. Therefore, perfusion is decreased to a kidney with afferent lesions and the renal scan to looks WORSE. Bottom line: renal scans appear WORSE with captopril administration if there is a lesion in the afferent arteriole. See: renal artery stenosis
(12 Dec 1998)
carcinoma, renal cell Carcinoma of the renal parenchyma usually occurring in middle age or later and composed of tubular cells in varying arrangements. It was first described in 1826. Possible causal factors are environmental, hormonal, cellular, and genetic. Smoking is a definite risk factor and obesity is associated with increased risk. Renal cell carcinoma accounts for approximately 3% of adult cancer; the male-female ratio is 2:1. It is more common among urban residents than rural.
(12 Dec 1998)
renal <anatomy> Pertaining to the kidney, nephric.
(18 Nov 1997)
renal adenocarcinoma <radiology> Hypernephroma, renal cell carcinoma, arises from proximal collecting tubule, 10% bilateral adenocarcinoma types: papillary, alveolar, onchocytoma vascularity, 85% hypervascular (require pre-op embolization), 10% hypovascular (usually papillary type), 5% avascular associated with: tuberous sclerosis, von Hippel-Lindau syndrome see also: staging
(12 Dec 1998)
renal adenocarcinoma: staging <radiology> Typical presentation: Haematuria . . . . . 70% Fever . . . . . . . 16% Pain . . . . . . . . 50% Polycythemia . . . . 3% Palpable mass . . . 20% Anatomic staging (TNM): T1 Small tumour, kidney not enlarged T2 Large tumour, contained within renal capsule T3 Extension into perinephric fat or renal vein T4 Invasion of adjacent organs
(12 Dec 1998)
renal adenocarcinoma: vascularity <radiology> 85% hypervascular (require pre-op embolization), 10% hypovascular (usually the papillary type), 5% avascular also: 10% are bilateral
(12 Dec 1998)
renal agenesis <radiology> Associated with, duplicated vagina and/or uterus (mullerian duct anomaly), seminal vesicle cysts
(12 Dec 1998)
renal agents Drugs used for their effects on the kidneys' regulation of body fluid composition and volume. The most commonly used are the diuretics. Also included are drugs used for their antidiuretic and uricosuric actions, for their effects on the kidneys' clearance of other drugs, and for diagnosis of renal function.
(12 Dec 1998)
renal amyloidosis Renal deposits of amyloid, especially in glomerular capillary walls, which may cause albuminuria and the nephrotic syndrome.
Synonym: amyloid nephrosis.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á